United States Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices - Product Image

United States Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

  • ID: 4342807
  • Report
  • Region: United States
  • 980 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • AstraZeneca Plc
  • Baxter International Inc
  • Boehringer Ingelheim GmbH
  • Edwards Lifesciences Corp
  • GlaxoSmithKline Plc
  • Medtronic Plc
  • MORE
United States Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

Summary

The new report, "United States Drug Delivery Devices Market Outlook to 2023", provides key market data on the United States Drug Delivery Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
  • Market size and company share data for Drug Delivery Devices market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.
  • Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.
  • 2016 company shares and distribution shares data for each of the market categories.
  • Global corporate-level profiles of key companies operating within the United States Drug Delivery Devices market.
  • Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer Ingelheim GmbH, Baxter International Inc, Medtronic plc and others.
Reasons to buy
  • Develop business strategies by identifying the key market categories poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AstraZeneca Plc
  • Baxter International Inc
  • Boehringer Ingelheim GmbH
  • Edwards Lifesciences Corp
  • GlaxoSmithKline Plc
  • Medtronic Plc
  • MORE
1 Table of Contents
2 Introduction
2.1 What Is This Report About?
2.2 Drug Delivery Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Drug Delivery Devices Market, United States
3.1 Drug Delivery Devices Market, United States, Revenue ($m), 2009-2023
3.2 Drug Delivery Devices Market, United States, Revenue Mix ($m), 2016
3.3 Drug Delivery Devices Market, United States, Category Contribution by Revenue ($m), 2016
3.4 Drug Delivery Devices Market, United States, Category Comparison by Revenue ($m), 2009-2023
3.5 Drug Delivery Devices Market, United States, Revenue ($m), 2009-2016
3.6 Drug Delivery Devices Market, United States, Revenue ($m), 2016-2023
3.7 Drug Delivery Devices Market, United States, Volume (Units), 2009-2023
3.8 Drug Delivery Devices Market, United States, Volume (Units), 2009-2016
3.9 Drug Delivery Devices Market, United States, Volume (Units), 2016-2023
3.10 Drug Delivery Devices Market, United States, Company Share by Revenue ($m), 2016
4 Central Venous Catheters Market, United States
4.1 Central Venous Catheters Market, United States, Revenue Mix ($m), 2016
4.2 Central Venous Catheters Market, United States, Segment Contribution (%), 2016
4.3 Central Venous Catheters Market, United States, Revenue ($m), 2009-2016
4.4 Central Venous Catheters Market, United States, Revenue ($m), 2016-2023
4.5 Central Venous Catheters Market, United States, Volume (Units), 2009-2016
4.6 Central Venous Catheters Market, United States, Volume (Units), 2016-2023
4.7 Central Venous Catheters Market, United States, Distribution Share by Revenue ($m), 2015-2016
4.8 Central Venous Catheters Market, United States, Company Share by Revenue ($m), 2016
5 Infusion Systems Market, United States
5.1 Infusion Systems Market, United States, Revenue Mix ($m), 2016
5.2 Infusion Systems Market, United States, Segment Contribution (%), 2016
5.3 Infusion Systems Market, United States, Revenue ($m), 2009-2016
5.4 Infusion Systems Market, United States, Revenue ($m), 2016-2023
5.5 Infusion Systems Market, United States, Volume (Units), 2009-2016
5.6 Infusion Systems Market, United States, Volume (Units), 2016-2023
5.7 Infusion Systems Market, United States, Distribution Share by Revenue ($m), 2015-2016
5.8 Infusion Systems Market, United States, Company Share by Revenue ($m), 2016
6 Needle Free Injections Market, United States
6.1 Needle Free Injections Market, United States, Revenue ($m), 2009-2016
6.2 Needle Free Injections Market, United States, Revenue ($m), 2016-2023
6.3 Needle Free Injections Market, United States, Volume (Units), 2009-2016
6.4 Needle Free Injections Market, United States, Volume (Units), 2016-2023
6.5 Needle Free Injections Market, United States, Distribution Share by Revenue ($m), 2015-2016
6.6 Needle Free Injections Market, United States, Company Share by Revenue ($m), 2016
7 Metered Dose Inhaler Devices Market, United States
7.1 Metered Dose Inhaler Devices Market, United States, Revenue ($m), 2009-2016
7.2 Metered Dose Inhaler Devices Market, United States, Revenue ($m), 2016-2023
7.3 Metered Dose Inhaler Devices Market, United States, Volume (Units), 2009-2016
7.4 Metered Dose Inhaler Devices Market, United States, Volume (Units), 2016-2023
7.5 Metered Dose Inhaler Devices Market, United States, Distribution Share by Revenue ($m), 2015-2016
7.6 Metered Dose Inhaler Devices Market, United States, Company Share by Revenue ($m), 2016
8 Overview of Key Companies in United States, Drug Delivery Devices Market
8.1 GlaxoSmithKline Plc
8.2 Teleflex Inc
8.3 AstraZeneca Plc
8.4 C. R. Bard Inc
8.5 Hospira Inc
8.6 Becton Dickinson and Co
8.7 Edwards Lifesciences Corp
8.8 Baxter International Inc
8.9 Boehringer Ingelheim GmbH
8.10 Medtronic Plc
8.11 Smiths Medical
8.12 B. Braun Melsungen AG
8.13 Pfizer Inc
8.14 Fresenius Kabi AG
8.15 Merck & Co Inc
9 Drug Delivery Devices Market Pipeline Products
10 Financial Deals Landscape
10.1 Acquisition
10.2 Asset Transactions
10.3 Debt Offerings
10.4 Equity Offerings
10.5 Merger
10.6 Partnerships
10.7 Private Equity
10.8 Venture Financing
11 Recent Developments
11.1 Corporate Communications
11.2 Financial Announcements
11.3 Government and Public Interest
11.4 Legal And Regulatory
11.5 Other Significant Developments
11.6 Product News
11.7 Strategy And Business Planning
12 Appendix
12.1 Research Methodology
12.2 Consulting
12.3 Contact
12.4 Disclaimer

List of Tables
Table 1: Drug Delivery Devices Market, United States, Revenue ($m), USD Constant, 2009-2023
Table 2: Drug Delivery Devices Market, United States, Category Contribution by Revenue ($m), 2016
Table 3: Drug Delivery Devices Market, United States, Category Comparison by Revenue ($m), 2009-2023
Table 4: Drug Delivery Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Table 5: Drug Delivery Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 6: Drug Delivery Devices Market, United States, Volume (Units), 2009-2023
Table 7: Drug Delivery Devices Market, United States, Volume (Units), Historic, 2009-2016
Table 8: Drug Delivery Devices Market, United States, Volume (Units), Forecast, 2016-2023
Table 9: Drug Delivery Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2016
Table 10: Central Venous Catheters Market, United States, Segment Contribution (%), 2016
Table 11: Central Venous Catheters Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Table 12: Central Venous Catheters Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 13: Central Venous Catheters Market, United States, Volume (Units), Historic, 2009-2016
Table 14: Central Venous Catheters Market, United States, Volume (Units), Forecast, 2016-2023
Table 15: Central Venous Catheters Market, United States, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 16: Central Venous Catheters Market, United States, Company Share by Revenue ($m), USD Constant, 2016
Table 17: Infusion Systems Market, United States, Segment Contribution (%), 2016
Table 18: Infusion Systems Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Table 19: Infusion Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 20: Ambulatory Infusion Pumps Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Table 21: Syringe Pumps Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Table 22: Ambulatory Infusion Pumps Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 23: Syringe Pumps Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 24: Infusion Systems Market, United States, Volume (Units), Historic, 2009-2016
Table 25: Infusion Systems Market, United States, Volume (Units), Forecast, 2016-2023
Table 26: Ambulatory Infusion Pumps Market, United States, Volume (Units), Historic, 2009-2016
Table 27: Syringe Pumps Market, United States, Volume (Units), Historic, 2009-2016
Table 28: Ambulatory Infusion Pumps Market, United States, Volume (Units), Forecast, 2016-2023
Table 29: Syringe Pumps Market, United States, Volume (Units), Forecast, 2016-2023
Table 30: Infusion Systems Market, United States, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 31: Infusion Systems Market, United States, Company Share by Revenue ($m), USD Constant, 2016
Table 32: Needle Free Injections Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Table 33: Needle Free Injections Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 34: Needle Free Injections Market, United States, Volume (Units), Historic, 2009-2016
Table 35: Needle Free Injections Market, United States, Volume (Units), Forecast, 2016-2023
Table 36: Needle Free Injections Market, United States, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 37: Needle Free Injections Market, United States, Company Share by Revenue ($m), USD Constant, 2016
Table 38: Metered Dose Inhaler Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Table 39: Metered Dose Inhaler Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 40: Metered Dose Inhaler Devices Market, United States, Volume (Units), Historic, 2009-2016
Table 41: Metered Dose Inhaler Devices Market, United States, Volume (Units), Forecast, 2016-2023
Table 42: Metered Dose Inhaler Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 43: Metered Dose Inhaler Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2016
Table 44: Drug Delivery Devices Market Pipeline Products
Table 45: Peaceful Union Acquires Sharklet Technologies
Table 46: Serum Institute of India Acquires Nanotherapeutics for USD78.2 Million
Table 47: Becton, Dickinson to Acquire C. R. Bard for USD24 Billion
Table 48: Shire May Acquire Radius Health
Table 49: PixarBio Terminates Acquisition of InVivo Therapeutics for USD77 Million
Table 50: Merck and Allergan May Acquire Biogen
Table 51: ICU Medical Acquires Hospira Infusion Systems Business from Pfizer
Table 52: PAVmed Raises USD5 Million in Private Placement of Notes and Warrants
Table 53: Becton, Dickinson to Raise USD725 Million in Public Offering of 2.133% Notes Due 2019
Table 54: Becton, Dickinson to Raise USD1 Billion in Public Offering of 2.404% Notes Due 2020
Table 55: Becton, Dickinson to Raise USD1.8 Billion in Public Offering of 2.894% Notes Due 2022
Table 56: Becton, Dickinson to Raise USD500 Million in Public Offering of Floating Rate Notes Due 2022
Table 57: Becton, Dickinson to Raise USD1.75 Billion in Public Offering of 3.363% Notes Due 2024
Table 58: Becton, Dickinson to Raise USD2.4 Billion in Public Offering of 3.7% Notes Due 2027
Table 59: Becton, Dickinson to Raise USD1.5 Billion in Public Offering of 4.669% Notes Due 2047
Table 60: Becton, Dickinson to Raise USD788 Million in Public Offering of 0.368% Notes Due 2019
Table 61: Skinvisible Raises USD0.2 Million in Issue of 10% Convertible Promissory Notes Due 2018
Table 62: Pfizer Raises USD1.3 Billion in Public Offering of Notes Due 2019
Table 63: Pfizer Raises USD1.06 Billion in Public Offering of Notes Due 2020
Table 64: Pfizer Raises USD1.06 Billion in Public Offering of 0.25% Notes Due 2022
Table 65: Pfizer Raises USD793.5 Million in Public Offering of 1% Notes Due 2027
Table 66: Pfizer Raises USD1.06 Billion in Private Placement of 4.2% Notes Due 2047
Table 67: Premier Biomedical Raises Funds in Third Tranche of Private Placement of 10% Notes Due 2016
Table 68: Catalent Prices Private Placement of 4.75% Notes Due 2024 for USD404.5 Million
Table 69: Becton Dickinson Prices Public Offering of 1% Notes Due 2022 for USD500 Million
Table 70: Becton Dickinson Prices Public Offering of 1.9% Notes Due 2026 for USD500 Million
Table 71: Pfizer Raises USD1 Billion in Public Offering of 1.7% Notes Due 2019
Table 72: Pfizer Raises USD1 Billion in Public Offering of 2.2% Notes Due 2021
Table 73: Pfizer Raises USD1.8 Billion in Public Offering of 3% Notes Due 2026
Table 74: Pfizer Raises USD1 Billion in Public Offering of 4% Notes Due 2036
Table 75: Pfizer Raises USD1.3 Billion in Public Offering of 4.125% Notes Due 2046
Table 76: Merck Raises USD544 Million in Public Offering of 1.375% Notes Due 2036
Table 77: Merck Raises USD544 Million in Public Offering of 0.5% Notes Due 2024
Table 78: KalVista Pharma Plans to Raise up to USD6 Million in Public Offering of Shares
Table 79: Clearside Biomedical Plans to Raise up to USD50 Million in Public Offering of Shares
Table 80: Delcath Systems to Raise USD2.4 Million in Private Placement of Series B Preferred Shares
Table 81: MannKind Plans to Raise Funds through Private Placement of Shares upon Exercise of Warrants
Table 82: PhaseRx Plans to Raise up to USD15 Million in Public Offering of Shares and Warrants
Table 83: EyeGate Pharma Raises USD10 Million in Public Offering of Shares and Warrants
Table 84: Zynerba Pharma Plans to Raise up to USD50 Million in Public Offering
Table 85: Savara Raises USD42.9 Million in Public Offering of Shares
Table 86: Premier Biomedical to Raise Funds through Public Offering of Shares
Table 87: MRI Interventions Raises USD13.3 Million in Private Placement of Units
Table 88: Alnylam Pharma Prices Public Offering of Shares for USD359.4 Million
Table 89: Corium International Raises USD40.3 Million in Public Offering of Shares
Table 90: Halozyme Therapeutics Raises USD143.8 Million in Public Offering of Shares
Table 91: Bellerophon Therapeutics to Raise USD30 Million in Private Placement of Shares
Table 92: Becton Dickinson Raises USD2.47 Billion in Public Offering of Shares
Table 93: Becton Dickinson Raises USD2.47 Billion in Public Offering of Depositary Shares
Table 94: Savara to Raise up to USD18 Million in Public Offering of Shares
Table 95: BioPharmX Raises USD5 Million in Private Placement of Shares and Warrants
Table 96: NanoCarrier Agrees to Invest in Tocagen
Table 97: Capnia Files Registration Statement for Secondary Offering of Shares
Table 98: Adamis Pharma Raises USD17.3 Million in Public Offering of Shares
Table 99: AngioDynamics Prices Public Offering of Shares for USD38 Million
Table 100: Tocagen Raises USD97.8 Million in IPO
Table 101: Premier Biomedical Raises USD0.3 Million in First Tranche of Private Placement of Shares and Warrants
Table 102: Catalyst Biosciences Raises USD20.7 Million in Public Offering of Units
Table 103: Alliqua BioMedical Raises USD2.8 Million in Private Placement of Shares
Table 104: Evoke Pharma Raises USD8 Million in Public Offering of Shares
Table 105: Windtree Therapeutics Raises USD10.5 Million in Private Placement of Units
Table 106: pSivida Plans to Raise Upto USD20 Million in Public Offering of Shares
Table 107: Galena Biopharma Raises Up to USD15.5 Million in Public Offering of Shares and Warrants
Table 108: Valeritas Files Registration Statement for IPO for up to USD50 Million
Table 109: PAVmed to Raise USD10.4 Million in Private Placement of Shares upon Exercise of Warrants
Table 110: Premier Biomedical Withdraws Public Offering of Shares
Table 111: PAVmed Raises Additional Funds in Second and Final Tranche of Private Placement of Units
Table 112: Corium International Raises USD20 Million in Public Offering of Shares
Table 113: Nu-Med Plus Raises USD0.3 Million in Private Placement of Shares
Table 114: Capnia Raises USD2 Million in First Tranche of Private Placement of Shares
Table 115: PAVmed Raises USD1.5 Million in First Tranche of Private Placement of Units
Table 116: Zynerba Pharma Announces Underwriters Exercise of Over-Allotment of Public Offering of Shares
Table 117: Heron Therapeutics Raises USD172.6 Million in Public Offering of Shares
Table 118: Braeburn Pharma to Raise USD40 Million in Private Placement of Shares
Table 119: Capnia Raises USD10 Million in Private Placement of Shares
Table 120: Milestone Scientific Completes Underwriters Partial Exercise of Over-Allotment Option of Public Offering of Shares
Table 121: AngioDynamics Prices Public Offering of Shares for USD32 Million
Table 122: PAVmed to Raise USD5.3 Million in Private Placement of Shares upon Exercise of Warrants
Table 123: ConvaTec Raises USD1.8 Billion in IPO
Table 124: Galena Biopharma to Raise Funds in Public Offering of Shares
Table 125: BioPharmX Raises USD12.5 Million in Public Offering of Units and Warrants
Table 126: Delcath Systems Prices Public Offering Shares and Warrants for USD1.3 Million
Table 127: T2 Biosystems Raises USD40 Million in Private Placement of Shares
Table 128: Intarcia Therapeutics Raises USD215 Million in First Tranche of Private Placement of Shares
Table 129: Catalent to Raise Funds through Public Offering of Shares
Table 130: MRI Interventions to Raise USD4.3 Million in Private Placement of Units
Table 131: BioMarin Pharma Prices Public Offering of Shares for USD720 Million
Table 132: Osprey Medical to Raise USD0.8 Million in Share Purchase Plan of CDIs
Table 133: Adamis Pharma to Raise USD11 Million in Private Placement of Units
Table 134: Dipexium Pharma Merges with PLx Pharma
Table 135: Infuseon Therapeutics Enters into Agreement with Oncosynergy
Table 136: Nobilis Therapeutics Enters into Agreement with Submersible Systems
Table 137: MannKind and One Drop to Enter into Agreement
Table 138: TWi Pharma Enters into Agreement with Intech Biopharm
Table 139: United Therapeutics Enters into Licensing Agreement with Respira Therapeutics
Table 140: Audax Medical Enters into Licensing Agreement with Northeastern University
Table 141: CannaRoyalty Enters into Licensing Agreement with NuTrae
Table 142: ViaCyte Enters into Research Agreement with W. L. Gore & Associates
Table 143: OncoSec Medical Enters into Agreement with Inhibrx
Table 144: Northwell Health Enters into Partnership with United Therapeutics
Table 145: PharmaJet Enters into Agreement with Serum Institute of India
Table 146: Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs
Table 147: Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma
Table 148: Hikma Pharma Enters into Licensing Agreement with Orion
Table 149: A1 Group Enters into Licensing and Distribution Agreement ?with Novaceutical Sciences
Table 150: 3M Drug Delivery Systems Partners with Panacea Pharma
Table 151: Neuronex Enters Into Licensing Agreement With SK Biopharmaceuticals For DZNS Technology
Table 152: Pfizer Terminates its Licensing Agreement with pSivida
Table 153: Iatric Systems Enters into Agreement with Hospira
Table 154: Tepha Enters into Agreement with Metabolix
Table 155: Bayer Enters into Licensing Agreement with DelSiTech
Table 156: ALZYN Enters into Licensing Agreement with Transdermal Delivery Solutions
Table 157: Themis Medicare Enters into Agreement with Nevakar
Table 158: Qualcomm Partners with Boehringer Ingelheim Pharma
Table 159: SkinJect Enters into Licensing Agreement with University of Pittsburgh
Table 160: BioCorRx Enters into Licensing Agreement with Therakine
Table 161: 3i Group to Invest USD136 Million in Cirtec Medical Systems from Century Park Capital Partners
Table 162: AGIC Capital to Acquire Ritedose From Olympus Partners
Table 163: 410 Medical Raises USD3.3 Million in Series A Financing
Table 164: Mentor Capital Invests USD1 Million in GW Pharma
Table 165: Otomagnetics Raises USD0.3 Million in Venture Financing
Table 166: Pharmajet Raises USD3 Million in Venture Financing
Table 167: 410 Medical Raises Additional USD2.1 Million in Series A Financing
Table 168: NexGen Medical Systems Raises USD1.5 Million in Venture Financing
Table 169: Xeris Pharma Raises Additional USD30 Million in Series C Financing
Table 170: Respira Therapeutics to Raise Funds through Series B Preferred Stock Financing
Table 171: Ivenix Raises USD50 Million in First Tranche of Equity Financing
Table 172: Ivenix Raises USD10 Million in Venture Financing
Table 173: Surefire Medical Raises USD12.8 Million in First Round of Series D Financing
Table 174: Unilife Raises USD5 Million in Venture Financing
Table 175: iVeena Delivery Systems to Raise USD1 Million in Venture Financing
Table 176: NapaJen Pharma to Raise Funds in Equity Financing
Table 177: Impel NeuroPharma Raises USD21 Million in First Tranche of Series C Financing
Table 178: Tocagen Raises USD2.73 Million in Venture Financing
Table 179: Impel NeuroPharma Raises USD22.3 Million in Venture Financing
Table 180: Unilife Raises USD10.6 Million in Financing Round
Table 181: Propeller Health Raises USD21.5 Million in Series C Financing
Table 182: BioQ Pharma Raises USD15 Million in Financing Round
Table 183: Enable Injections Raises USD30 Million in Series A Financing
Table 184: QuiO Technologies Raises USD1.05 Million in Seed Financing
Table 185: Impel NeuroPharma Raises USD0.08 Million in Venture Financing
Table 186: Kaio Therapy Raises USD0.2 Million in Venture Financing
Table 187: Credence MedSystems Raises USD15 Million in Series A Financing
Table 188: Chrono Therapeutics Raises USD47.6 Million in Series B Financing
Table 189: Enable Injections Raises USD10 Million in Venture Financing
Table 190: Fe3 Medical Raises Additional USD3.5 Million in Series B Financing Round

List of Figures
Figure 1: Drug Delivery Devices Market, United States, Revenue ($m), USD Constant, 2009-2023
Figure 2: Drug Delivery Devices Market, United States, Revenue Mix ($m), 2016
Figure 3: Drug Delivery Devices Market, United States, Category Contribution (%), 2016
Figure 4: Drug Delivery Devices Market, United States, Category Comparison by Revenue ($m), 2009-2023
Figure 5: Drug Delivery Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 6: Drug Delivery Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 7: Drug Delivery Devices Market, United States, Volume (Units), 2009-2023
Figure 8: Drug Delivery Devices Market, United States, Volume (Units), Historic, 2009-2016
Figure 9: Drug Delivery Devices Market, United States, Volume (Units), Forecast, 2016-2023
Figure 10: Drug Delivery Devices Market, United States, Company Share (%) 2016
Figure 11: Central Venous Catheters Market, United States, Revenue Mix ($m), 2016
Figure 12: Central Venous Catheters Market, United States, Segment Contribution (%), 2016
Figure 13: Central Venous Catheters Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 14: Central Venous Catheters Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 15: Central Venous Catheters Market, United States, Volume (Units), Historic, 2009-2016
Figure 16: Central Venous Catheters Market, United States, Volume (Units), Forecast, 2016-2023
Figure 17: Central Venous Catheters Market, United States, Company Share (%) 2016
Figure 18: Infusion Systems Market, United States, Revenue Mix ($m), 2016
Figure 19: Infusion Systems Market, United States, Segment Contribution (%), 2016
Figure 20: Infusion Systems Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 21: Infusion Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 22: Ambulatory Infusion Pumps Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 23: Syringe Pumps Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 24: Ambulatory Infusion Pumps Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 25: Syringe Pumps Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 26: Infusion Systems Market, United States, Volume (Units), Historic, 2009-2016
Figure 27: Infusion Systems Market, United States, Volume (Units), Forecast, 2016-2023
Figure 28: Ambulatory Infusion Pumps Market, United States, Volume (Units), Historic, 2009-2016
Figure 29: Syringe Pumps Market, United States, Volume (Units), Historic, 2009-2016
Figure 30: Ambulatory Infusion Pumps Market, United States, Volume (Units), Forecast, 2016-2023
Figure 31: Syringe Pumps Market, United States, Volume (Units), Forecast, 2016-2023
Figure 32: Infusion Systems Market, United States, Company Share (%) 2016
Figure 33: Needle Free Injections Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 34: Needle Free Injections Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 35: Needle Free Injections Market, United States, Volume (Units), Historic, 2009-2016
Figure 36: Needle Free Injections Market, United States, Volume (Units), Forecast, 2016-2023
Figure 37: Needle Free Injections Market, United States, Company Share (%) 2016
Figure 38: Metered Dose Inhaler Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 39: Metered Dose Inhaler Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 40: Metered Dose Inhaler Devices Market, United States, Volume (Units), Historic, 2009-2016
Figure 41: Metered Dose Inhaler Devices Market, United States, Volume (Units), Forecast, 2016-2023
Figure 42: Metered Dose Inhaler Devices Market, United States, Company Share (%) 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • GlaxoSmithKline Plc
  • Teleflex Inc
  • AstraZeneca Plc
  • C. R. Bard Inc
  • Hospira Inc
  • Becton Dickinson and Co
  • Edwards Lifesciences Corp
  • Baxter International Inc
  • Boehringer Ingelheim GmbH
  • Medtronic Plc
  • Smiths Medical
  • B. Braun Melsungen AG
  • Pfizer Inc
  • Fresenius Kabi AG
  • Merck & Co Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll